Leukemia & Lymphoma, Volume 56, Issue 9 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 9 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Is 70 the new 60? New international prognostic index with an older age cut-off for diffuse large B-cell lymphoma
N. George Mikhaeel
Pages: 2487-2488
Published online: 12 May 2015
CitationforIs 70 the new 60? New international prognostic index with an older age cut-off for diffuse large B-cell lymphoma | Full Text | References | PDF (370.4 KB) | Supplemental
  • 129 Views
  • 5 CrossRef citations
  • 0Altmetric
Article Commentary
Immunochemotherapy in Waldenström macroglobulinemia – still the backbone of treatment
Christian Buske & J. F. Seymour
Pages: 2489-2490
Published online: 21 Sep 2015
CitationforImmunochemotherapy in Waldenström macroglobulinemia – still the backbone of treatment | Full Text | References | PDF (207.1 KB) | Supplemental
  • 170 Views
  • 7 CrossRef citations
  • 0Altmetric
Article Commentary
Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years
Aaron T. Gerds & Mikkael A. Sekeres
Pages: 2491-2492
Published online: 25 May 2015
CitationforAlbumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years | Full Text | References | PDF (298.9 KB) | Supplemental
  • 138 Views
  • 4 CrossRef citations
  • 0Altmetric

Reviews

Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis
John Mascarenhas
Pages: 2493-2497
Published online: 11 Feb 2015
AbstractforSelective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis | Full Text | References | PDF (562.7 KB) | Supplemental
  • 507 Views
  • 9 CrossRef citations
  • 0Altmetric
T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion
Zhi-Zhang Yang, Ai-Bin Liang & Stephen M. Ansell
Pages: 2498-2504
Published online: 08 Mar 2015
AbstractforT-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion | Full Text | References | PDF (578.4 KB) | Supplemental
  • 636 Views
  • 18 CrossRef citations
  • 0Altmetric
Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop
Brad S. Kahl, Leo I. Gordon, Martin Dreyling, Randy D. Gascoyne & Eduardo M. Sotomayor
Pages: 2505-2511
Published online: 25 May 2015
AbstractforAdvances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop | Full Text | References | PDF (512 KB) | Supplemental
  • 812 Views
  • 2 CrossRef citations
  • 0Altmetric

Clinical Dilemmas

When to recommend allogeneic transplant in multiple myeloma
Morie A. Gertz
Pages: 2512-2517
Published online: 18 Jun 2015
AbstractforWhen to recommend allogeneic transplant in multiple myeloma | Full Text | References | PDF (427 KB) | Supplemental
  • 569 Views
  • 9 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Catalytic mammalian target of rapamycin inhibitors as antineoplastic agents
Nisha A. Mohindra & Leonidas C. Platanias
Pages: 2518-2523
Published online: 12 May 2015
AbstractforCatalytic mammalian target of rapamycin inhibitors as antineoplastic agents | Full Text | References | PDF (437.2 KB) | Supplemental
  • 120 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience
José Carlos Jaime-Perez, Perla R. Colunga-Pedraza, César Homero Gutiérrez-Aguirre, Mónica Andrea Pinzón-Uresti, Olga G. Cantú-Rodríguez, José Luis Herrera-Garza & David Gómez-Almaguer
Pages: 2524-2528
Published online: 09 Feb 2015
AbstractforEfficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience | Full Text | References | PDF (436.9 KB) | Supplemental
  • 138 Views
  • 3 CrossRef citations
  • 0Altmetric
Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia
Agnieszka Pluta, Agnieszka Wierzbowska, Barbara Cebula-Obrzut, Piotr Pluta, Konrad Stępka, Anna Szmigielska-Kapłon, Olga Grzybowska-Izydorczyk, Magdalena Czemerska, Piotr Smolewski, Agata Wrzesien-Kus & Tadeusz Robak
Pages: 2529-2535
Published online: 20 Feb 2015
AbstractforPrognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia | Full Text | References | PDF (7.8 MB) | Supplemental
  • 226 Views
  • 14 CrossRef citations
  • 0Altmetric
Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy
Moshe C. Ornstein, Sudipto Mukherjee, Michael Keng, Paul Elson, Ramon V. Tiu, Yogenthiran Saunthararajah, Amanda Maggiotto, Madeline Schaub, Diane Banks, Anjali Advani, Matt Kalaycio, Jaroslaw P. Maciejewski & Mikkael A. Sekeres
Pages: 2536-2542
Published online: 20 Feb 2015
AbstractforImpact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy | Full Text | References | PDF (1.3 MB) | Supplemental
  • 297 Views
  • 14 CrossRef citations
  • 0Altmetric
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Elizabeth O. Hexner, John Mascarenhas, Josef Prchal, Gail J. Roboz, Maria R. Baer, Ellen K. Ritchie, David Leibowitz, Erin P. Demakos, Crystal Miller, James Siuty, Jill Kleczko, Leah Price, Grace Jeschke, Rona Weinberg, Titiksha Basu, Heike L. Pahl, Attilio Orazi, Vesna Najfeld, Roberto Marchioli, Judith D. Goldberg, Lewis R. Silverman & Ronald Hoffman
Pages: 2543-2551
Published online: 20 Feb 2015
AbstractforPhase I dose escalation study of lestaurtinib in patients with myelofibrosis | Full Text | References | PDF (636.4 KB) | Supplemental
  • 407 Views
  • 26 CrossRef citations
  • 0Altmetric
Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities
Omur Gokmen Sevindik, Zeynep Guc, Selda Kahraman, Serife Medeni Solmaz, Abdullah Katgi, Celal Acar, Inci Alacacioglu, Ozden Piskin, Guner Hayri Ozsan, Fatih Demirkan, Bulent Undar & Mehmet Ali Ozcan
Pages: 2552-2555
Published online: 06 Mar 2015
AbstractforHypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities | Full Text | References | PDF (527 KB) | Supplemental
  • 271 Views
  • 7 CrossRef citations
  • 0Altmetric
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry
Anne O. Gang, Michael Pedersen, Francesco d’Amore, Lars M. Pedersen, Bo A. Jensen, Paw Jensen, Michael B. Møller, Hans T. Mourits-Andersen, Robert S. Pedersen, Tobias W. Klausen & Peter de N. Brown
Pages: 2556-2562
Published online: 17 Feb 2015
AbstractforA clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry | Full Text | References | PDF (1.3 MB) | Supplemental
  • 374 Views
  • 18 CrossRef citations
  • 0Altmetric
Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis
Baochai Lin, Cuie Chen, Yan Qian & Jianhua Feng
Pages: 2563-2568
Published online: 03 Mar 2015
AbstractforPrognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis | Full Text | References | PDF (635.7 KB) | Supplemental
  • 451 Views
  • 24 CrossRef citations
  • 0Altmetric
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial
Luis Fayad, Stephen M. Ansell, Ranjana Advani, Bertrand Coiffier, Robert Stuart, Nancy L. Bartlett, Andres Forero-Torres, Kazimierz Kuliczkowski, David Belada, Edmund Ng & Jonathan G. Drachman
Pages: 2569-2578
Published online: 26 Feb 2015
AbstractforDacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial | Full Text | References | PDF (3.7 MB) | Supplemental
  • 3296 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access
Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma
Scott F. Huntington, Sunita D. Nasta, Stephen J. Schuster, Jalpa A. Doshi & Jakub Svoboda
Pages: 2579-2584
Published online: 11 Feb 2015
AbstractforUtility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 305 Views
  • 14 CrossRef citations
  • 0Altmetric
The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: results of an international, multicenter phase I/II study
Owen A. O’Connor, John Gerecitano, Henrik Van Deventer, John Hainsworth, Kelly M. Zullo, Khalil Saikali, Joseph Seroogy, Andrew Wolff & Rafael Escandón
Pages: 2585-2591
Published online: 10 Feb 2015
AbstractforThe addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: results of an international, multicenter phase I/II study | Full Text | References | PDF (469.6 KB) | Supplemental
  • 273 Views
  • 11 CrossRef citations
  • 0Altmetric
Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma
Souichi Shiratori, Mizuha Kosugi-Kanaya, Akio Shigematsu, Hajime Kobayashi, Satoshi Yamamoto, Naoki Kobayashi, Hiroshi Iwasaki, Akio Mori, Yasuyuki Kunieda, Tsutsumi Yutaka, Mitsutoshi Kurosawa, Yasutaka Kakinoki, Tomoyuki Endo, Takeshi Kondo, Satoshi Hashino, Takanori Teshima & for the North Japan Hematology Study Group (NJHSG)
Pages: 2592-2597
Published online: 24 Feb 2015
AbstractforUltra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 244 Views
  • 7 CrossRef citations
  • 0Altmetric
Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas
Eva Kimby, Björn Östenstad, Peter Brown, Hans Hagberg, Martin Erlanson, Harald Holte, Ola Linden, Ann-Sofie Johansson, Tomas Ahlgren, Karin Wader, Björn Engelbrekt Wahlin, Jan Delabie, Christer Sundström & for the Nordic Lymphoma Group (NLG)
Pages: 2598-2607
Published online: 11 Mar 2015
AbstractforTwo courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas | Full Text | References | PDF (2.5 MB) | Supplemental
  • 641 Views
  • 23 CrossRef citations
  • 0Altmetric
Proton therapy in the management of non-Hodgkin lymphoma
Suzanne Sachsman, Stella Flampouri, Zuofeng Li, James Lynch, Nancy P. Mendenhall & Bradford S. Hoppe
Pages: 2608-2612
Published online: 18 May 2015
AbstractforProton therapy in the management of non-Hodgkin lymphoma | Full Text | References | PDF (415.3 KB) | Supplemental
  • 1693 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma
Yingying Cui, Xin Li, Zhenchang Sun, Changsen Leng, Ken Young, Xiaolong Wu, Lei Zhang, Xiaorui Fu, Ling Li, Xudong Zhang, Yu Chang, Feifei Nan, Zhaoming Li, Jiaqin Yan, Zhiyuan Zhou, Mingzhi Zhang, Wencai Li, Guannan Wang & Dandan Zhang
Pages: 2613-2618
Published online: 11 Mar 2015
AbstractforSafety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma | Full Text | References | PDF (631.8 KB) | Supplemental
  • 484 Views
  • 10 CrossRef citations
  • 0Altmetric
A classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders
Ryan Healey, Christopher Naugler, Lawrence de Koning & Jay L. Patel
Pages: 2619-2624
Published online: 06 Mar 2015
AbstractforA classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders | Full Text | References | PDF (4.1 MB) | Supplemental
  • 333 Views
  • 10 CrossRef citations
  • 0Altmetric
Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood
Carsten Hirt, M. Constanza Camargo, Kelly J. Yu, Stephen M. Hewitt, Gottfried Dölken & Charles S. Rabkin
Pages: 2625-2629
Published online: 17 Mar 2015
AbstractforRisk of follicular lymphoma associated with BCL2 translocations in peripheral blood | Full Text | References | PDF (382.8 KB) | Supplemental
  • 231 Views
  • 7 CrossRef citations
  • 0Altmetric
Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients
Young Wha Koh, Hee Sang Hwang, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh
Pages: 2630-2636
Published online: 04 Feb 2015
AbstractforPrognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients | Full Text | References | PDF (1.4 MB) | Supplemental
  • 345 Views
  • 11 CrossRef citations
  • 0Altmetric
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia
Alessandra Tedeschi, Paola Picardi, Simone Ferrero, Giulia Benevolo, Gloria Margiotta Casaluci, Marzia Varettoni, Claudia Baratè, Marina Motta, Guido Gini, Maria Cecilia Goldaniga, Carlo Visco, Francesco Zaja, Valeria Belsito Petrizi, Erika Ravelli, Massimo Gentile, Marina Aurora Urbano, Silvia Franceschetti, Paola Ghione, Lorella Orsucci, Anna Maria Frustaci, Gianluca Gaidano, Umberto Vitolo & Enrica Morra
Pages: 2637-2642
Published online: 14 Mar 2015
AbstractforBendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia | Full Text | References | PDF (602.2 KB) | Supplemental
  • 1069 Views
  • 48 CrossRef citations
  • 0Altmetric
Socioeconomic status is independently associated with overall survival in patients with multiple myeloma
Mark A. Fiala, Joseph D. Finney, Jingxia Liu, Keith E. Stockerl-Goldstein, Michael H. Tomasson, Ravi Vij & Tanya M. Wildes
Pages: 2643-2649
Published online: 08 Mar 2015
AbstractforSocioeconomic status is independently associated with overall survival in patients with multiple myeloma | Full Text | References | PDF (663.5 KB) | Supplemental
  • 562 Views
  • 42 CrossRef citations
  • 0Altmetric
Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma
Anne K. Mylin, Niels Abildgaard, Julia S. Johansen, Lene Heickendorff, Svend Kreiner, Anders Waage, Ingemar Turesson, Peter Gimsing & for the Nordic Myeloma Study Group
Pages: 2650-2659
Published online: 11 Feb 2015
AbstractforSerum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 268 Views
  • 14 CrossRef citations
  • 0Altmetric
Variation in incidence and survival by ethnicity for patients with myeloma in England (2002–2008)
E. Faye Samy, James Ross, Edward Bolton, Eva J. Morris & Steven E. Oliver
Pages: 2660-2667
Published online: 11 Mar 2015
AbstractforVariation in incidence and survival by ethnicity for patients with myeloma in England (2002–2008) | Full Text | References | PDF (830.7 KB) | Supplemental
  • 372 Views
  • 10 CrossRef citations
  • 0Altmetric
Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant
Victor H. Jimenez-Zepeda, Donna E. Reece, Suzanne Trudel, Christine Chen, Norman Franke, Andrew Winter, Rodger Tiedemann & Vishal Kukreti
Pages: 2668-2673
Published online: 24 Feb 2015
AbstractforAbsolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant | Full Text | References | PDF (834.7 KB) | Supplemental
  • 448 Views
  • 25 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation
Hui-Jen Tsai, Neng-Yao Shih, Sung-Hsin Kuo, Ann-Lii Cheng, Hui-You Lin, Tsai-Yun Chen, Kung-Chao Chang, Sheng-Fung Lin, Jeffrey S. Chang & Li-Tzong Chen
Pages: 2674-2682
Published online: 21 Jan 2015
AbstractforAUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation | Full Text | References | PDF (5.9 MB) | Supplemental
  • 283 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Epigenetic regulation of microRNA expression in Hodgkin lymphoma
Alfons Navarro, Tania Díaz, Anna Cordeiro, Marina Díaz Beyá, Gerardo Ferrer, Dolors Fuster, Antonio Martinez & Mariano Monzó
Pages: 2683-2689
Published online: 18 Jun 2015
AbstractforEpigenetic regulation of microRNA expression in Hodgkin lymphoma | Full Text | References | PDF (5.6 MB) | Supplemental
  • 362 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation
Fariba Fouladi, Lutz B. Jehn, Stephan K. Metzelder, Florian Hub, Katharina Henkenius, Andreas Burchert, Cornelia Brendel, Thorsten Stiewe & Andreas Neubauer
Pages: 2690-2698
Published online: 03 Mar 2015
AbstractforSorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation | Full Text | References | PDF (6.6 MB) | Supplemental
  • 1386 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children
Youssef M. Mosaad, Nashwa K. Abousamra, Rasha Elashery, Iman M. Fawzy, Omar A. Sharaf Eldein, Doaa M. Sherief & Hend M. M. El Azab
Pages: 2699-2705
Published online: 24 Feb 2015
AbstractforMethylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children | Full Text | References | PDF (1.8 MB) | Supplemental
  • 142 Views
  • 12 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia
Neus Ruiz-Xivillé, Isabel Granada, Diana Campos, Adela Cisneros, Javier Grau, Marisol Xandri, Montserrat Arnan, Natalia Lloveras, Lourdes Escoda, Llorenç Font, Fuensanta Millá & Josep-Maria Ribera
Pages: 2706-2708
Published online: 20 Feb 2015
First Page PreviewforClinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia | Full Text | References | PDF (3.5 MB) | Supplemental
  • 108 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant
Jacqueline O’Toole, Steven Ades, Brenda L Waters, Zubin Agarwal & Gurpreet Lamba
Pages: 2709-2710
Published online: 11 Feb 2015
CitationforDelayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant | Full Text | References | PDF (2.7 MB) | Supplemental
  • 135 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Treatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy
Delphine Sauvage, Florence Roufosse, Ismail Sanoussi, Martial Massin, Shancy Rooze, Andrée De Ville, Nadira Azzi, Sophie Huybrechts, Laurence Dedeken, Christine Devalck & Alina Ferster
Pages: 2711-2713
Published online: 25 Feb 2015
First Page PreviewforTreatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy | Full Text | References | PDF (485 KB) | Supplemental
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation
Simon McAuliffe, Ross Brown, Alberto Catalano, P. Joy Ho, Najah Nassif, Narelle Woodland, Derek Hart, Claire Weatherburn, Shihong Yang, Hayley Suen, Cheryl Paul, Douglas Joshua & John Gibson
Pages: 2714-2716
Published online: 17 Feb 2015
First Page PreviewforUsing digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation | Full Text | References | PDF (693.1 KB) | Supplemental
  • 218 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Lenalidomide-associated hemolytic anemia
Ming Y. Lim, Jay S. Raval, Kristy L. Richards, Joshua F. Zeidner & Matthew C. Foster
Pages: 2717-2719
Published online: 02 Mar 2015
First Page PreviewforLenalidomide-associated hemolytic anemia | Full Text | References | PDF (419.6 KB) | Supplemental
  • 517 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Immunohistochemical expression of cell cycle proteins in multiple myeloma
Ilias Pessach, Alexandra Papoudou-Bai, Anna Goussia, Sevasti Kamina, Marie-Christine Kyrtsonis, Konstantinos L. Bourantas & Panagiotis Kanavaros
Pages: 2720-2723
Published online: 04 Feb 2015
First Page PreviewforImmunohistochemical expression of cell cycle proteins in multiple myeloma | Full Text | References | PDF (8.5 MB) | Supplemental
  • 91 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
Anita T. Simonsen, Marie Schou, Camilla D. Sørensen, Hans H. N. Bentzen & Charlotte G. Nyvold
Pages: 2724-2727
Published online: 11 Feb 2015
First Page PreviewforSOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma? | Full Text | References | PDF (2.2 MB) | Supplemental
  • 374 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma
Andrea Messori, Valeria Fadda, Dario Maratea & Sabrina Trippoli
Pages: 2728-2730
Published online: 11 Mar 2015
First Page PreviewforComparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma | Full Text | References | PDF (1.1 MB) | Supplemental
  • 155 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Novel STAT5B–RARA fusion transcript in acute promyelocytic leukemia: identification and treatment response
Yan-Yu Wang, Jie Hao, Zhan-Yun Liu, Xiang-Qin Weng, Yan Sheng, Chun-Lei Jiang, Yong-Mei Zhu, Bing Chen, Shu-Min Xiong, Jun-Min Li, Qiu-Sheng Chen, Hao-yue Chen, Chun Qiao & Yu Chen
Pages: 2731-2734
Published online: 11 Feb 2015
First Page PreviewforNovel STAT5B–RARA fusion transcript in acute promyelocytic leukemia: identification and treatment response | Full Text | References | PDF (7.9 MB) | Supplemental
  • 289 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
A cryptic submicroscopic deletion of 5’ MLF1–3’ NPM1 segment on derivative chromosome 3 in a patient with acute myeloid leukemia with t(3;5)(q25;q35)
Man Gao, Guanjun Wang, Xianfu Wang, Young Mi Kim, Xianglan Lu, Jin Lu, Yue Gu, Hui Pang, Jiyun Lee, Andrea Sternenberger & Shibo Li
Pages: 2735-2738
Published online: 11 Feb 2015
First Page PreviewforA cryptic submicroscopic deletion of 5’ MLF1–3’ NPM1 segment on derivative chromosome 3 in a patient with acute myeloid leukemia with t(3;5)(q25;q35) | Full Text | References | PDF (13.3 MB) | Supplemental
  • 132 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Success of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera
Nicolas Noel, Ivan Sloma, Cédric Aumont, Olivier Hermine, Ali Turhan & Caroline Besson
Pages: 2739-2742
Published online: 06 Mar 2015
First Page PreviewforSuccess of interferon α therapy in a patient with hepatitis C virus-negative splenic marginal zone lymphoma associated with polycythemia vera | Full Text | References | PDF (2.6 MB) | Supplemental
  • 131 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Enteropathy-associated T-cell lymphoma in childhood: a case report and review of the literature
Marta Chisini, Francesco Bacci, Maria Stefania de Propris, Walter Barberi, Anna Guarini, Anna Paola Iori, Valentina Tabanelli, Maria Luisa Moleti, Emanuele Casciani, Robin Foà & Anna Maria Testi
Pages: 2743-2746
Published online: 09 Feb 2015
First Page PreviewforEnteropathy-associated T-cell lymphoma in childhood: a case report and review of the literature | Full Text | References | PDF (33.8 MB) | Supplemental
  • 744 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials
Ashley Marton, Abbas Kezouh, Tina Petrogiannis-Haliotis & Sarit Assouline
Pages: 2747-2749
Published online: 17 Feb 2015
First Page PreviewforBarriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials | Full Text | References | PDF (603.5 KB) | Supplemental
  • 118 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Yoshimi Ishii, Naoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, Kumiko Kishimoto, Eri Yamamoto, Satoshi Koyama, Yukako Hattori, Yuki Nakajima, Kenji Motohashi, Hirotaka Takasaki, Rika Kawasaki, Chizuko Hashimoto, Sachiya Takemura, Katsumichi Fujimaki, Hiroyuki Fujita, Rika Sakai, Shin Fujisawa, Shigeki Motomura & Yoshiaki Ishigatsubo
Pages: 2750-2752
Published online: 06 Mar 2015
First Page PreviewforDissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Full Text | References | PDF (985.1 KB) | Supplemental
  • 113 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles